CXCR4 and cancer: Our study is in concordance with this finding, showing a higher proportion of cancer stem cell population (CD133+ and CD133+, CXCR4+) in type 2 endometrial cancer with poor prognosis as compared to type 1 endometrial cancer with good prognosis.